Rheumatoid Arthritis India Drug Forecast and Market Analysis to 2023

1
Rheumatoid Arthritis India Drug Forecast and
Market Analysis to 2023
Market Reports On India
Market Reports On India
By http//www.marketreportsonindia.com/

2
Summary
Rheumatoid arthritis (RA) is a chronic autoimmune
disease which causes inflammation and deformity
of the joints. It affects over seven million
individuals in the 10MM covered in this report
(US, France, Germany, Italy, Spain, UK, Japan,
Australia, China, and India) and the prevalence
is expected to grow to just over 8.5 million
individuals by 2023. The anti-TNFs have been
effective in treating the signs and symptoms of
RA and inhibiting progression to erosive bone
disease. However, the landscape is quickly
changing with the introduction of biosimilars,
novel biologics, and a class of oral therapies
known as JAK inhibitors, all of which will change
the market dynamics between 2013 and 2023. With
the anti-TNFs as extremely effective therapies
for RA, the market is extremely competitive for
new entrants and will undergo further pressure as
biosimilars are approved and launch.


Contact No 91.22.27810772/ 73
Email Id info_at_marketreportsonindia.com
3
The drivers of growth in this market include the
increasing RA patient population, and economic
growth, which has led to increased investment in
the national healthcare system. However, Indian
physicians' preference for generics and
biosimilars, which have been known to launch
prior to patent expiry, has limited the growth of
branded products. In addition, because
intellectual property law is not enforced in
India, there is a disincentive for large
pharmaceutical companies to launch their products
in the country.


Contact No 91.22.27810772/ 73
Email Id info_at_marketreportsonindia.com
4
Scope
- Overview of Rheumatoid arthritis including
epidemiology, etiology, symptoms, diagnosis,
pathology and treatment guidelines as well as an
overview on the competitive landscape. -
Detailed information on the key drugs in the
India including product description, safety and
efficacy profiles as well as a SWOT analysis. -
Sales forecast for the top drugs in the India
from 2013-2023. - Analysis of the impact of key
events as well the drivers and restraints
affecting the India Rheumatoid arthritis market.


Contact No 91.22.27810772/ 73
Email Id info_at_marketreportsonindia.com
5
Reasons to buy - Understand and capitalize by
identifying products that are most likely to
ensure a robust return - Stay ahead of the
competition by understanding the changing
competitive landscape for Rheumatoid arthritis -
Effectively plan your MA and partnership
strategies by identifying drugs with the most
promising sales potential - Make more informed
business decisions from insightful and in-depth
analysis of drug performance - Obtain sales
forecast for drugs from 2013-2023 in the India


Contact No 91.22.27810772/ 73
Email Id info_at_marketreportsonindia.com
6
Table of Contents

1. Introduction 12
2. Catalyst 12
3. Related Reports 13
4. Upcoming Related Reports 16
5. Disease Overview 17
6. Etiology and Pathophysiology 17
7. Etiology 17
8. Pathophysiology 17
9. Symptoms 22
10. Prognosis 23

Contact No 91.22.27810772/ 73
Email Id info_at_marketreportsonindia.com
7
To view the full Executive Summary and Table of
Contents, please visit Rheumatoid Arthritis
India Drug Forecast and Market Analysis to
2023 Contact us Market Reports on
IndiaPhone no912227810772 / 73E-mail to
info_at_marketreportsonindia.com Website
https//www.marketreportsonindia.com